본문 바로가기
KERD
논문KCI 등재

Effect of a Diet with Unrestricted Sodium on Ascites in Patients with Hepatic Cirrhosis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: There has been debate on whether a sodium-restricted diet (SRD) should be used in cirrhotic patients with ascites in China in recent years. The purpose of this study was to compare the effect of sodium-restricted and unrestricted diets on plasma renin activity (PRA), renal blood flow (RBF) and ascites in patients with liver cirrhosis. Methods: Two hundred cirrhotic patients with ascites were randomly divided into two groups (98 cases in the sodium-unrestricted diet [SUD] group and 102 cases in the SRD group); 95 patients (96.94%) in the SUD group and 97 patients (95.1%) in the SRD group had post-hepatitis B cirrhosis. Results: Blood sodium and RBF were higher in SUD group than in SRD group (p<0.001), while PRA were significantly lower in SUD group than the SRD group 10 days after treatment (p<0.001). Renal impairment caused by low blood sodium was higher in SRD group than in SUD group (p<0.01). Ascites disappeared in higher proportion of patients in SUD group than in SRD group (p<0.001). Conclusions: SUD can increase the level of blood sodium and RBF, and be beneficial to diuresis and ascite reduction and disappearance.

Abstract

Background/Aims: There has been debate on whether a sodium-restricted diet (SRD) should be used in cirrhotic patients with ascites in China in recent years. The purpose of this study was to compare the effect of sodium-restricted and unrestricted diets on plasma renin activity (PRA), renal blood flow (RBF) and ascites in patients with liver cirrhosis. Methods: Two hundred cirrhotic patients with ascites were randomly divided into two groups (98 cases in the sodium-unrestricted diet [SUD] group and 102 cases in the SRD group); 95 patients (96.94%) in the SUD group and 97 patients (95.1%) in the SRD group had post-hepatitis B cirrhosis. Results: Blood sodium and RBF were higher in SUD group than in SRD group (p<0.001), while PRA were significantly lower in SUD group than the SRD group 10 days after treatment (p<0.001). Renal impairment caused by low blood sodium was higher in SRD group than in SUD group (p<0.01). Ascites disappeared in higher proportion of patients in SUD group than in SRD group (p<0.001). Conclusions: SUD can increase the level of blood sodium and RBF, and be beneficial to diuresis and ascite reduction and disappearance.

참고문헌 (21)

  1. Moore KP, "The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club", Hepatology, 38, pp.258~266 (2003)
  2. Runyon BA, "Management of adult patients with ascites due to cirrhosis", Hepatology, 39, pp.841~856 (2004)
  3. Zeng X, "My view of sodium restriction in the treatment of cirrhotic ascites", Chin J Dig, 27, pp.331~333 (2007)
  4. Gu XB, "Influence of diet with or without sodium restriction on renal flow and ascites subsidence of patients with cirrhosis", Chin J Dig, 28, pp.61~62 (2008)
  5. Gu XB, "Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis", Zhonghua Gan Zang Bing Za Zhi, 12, pp.370~ (2004)
  6. Gu XB, "Influence of sodium supplement and restriction on subsidence of cirrhotic ascites", Chin J Infect Dis, 22, pp.129~130 (2004)
  7. Liu JJ, "Sodium restriction to correct cirrhotic ascites and application of hypertonic NaCl in ascites patients", Clin Focus, 15, pp.1141~1143 (2000)
  8. Wang XC, "Color Doppler study on hepatorenal syndrome and renal artery hemodynamics in non-compensation period of cirrhosis", J Clin Hepatobiliary Dis, 12, pp.212~213 (1996)
  9. Liang CX, "Color Doppler study on renal artery hemodynamics of normal adults", J Ultrasonic Med, 11, pp.103~104 (1995)
  10. Domenicali M, "A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis", J Hepatol, 43, pp.92~97 (2005)
  11. Wong F, "The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis", Hepatology, 35, pp.1449~1458 (2002)
  12. Arroyo V, "Prognostic value of spontaneous hyponatremia in cirrhosis with ascites", Am J Dig Dis, 21, pp.249~256 (1976)
  13. Ginès P, "Aquaretic agents: a new potential treatment of dilutional hyponatremia in cirrhosis", J Hepatol, 24, pp.506~512 (1996)
  14. Sterns RH, "Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases", Ann Intern Med, 107, pp.656~664 (1987)
  15. Reynolds TB, "Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid", Gut, 19, pp.549~553 (1978)
  16. Gauthier A, "Salt or no salt in the treatment of cirrhotic ascites: a randomised study", Gut, 27, pp.705~709 (1986)
  17. Desai HG, "Salt restriction in ascites with cirrhosis of liver: will enhanced salt restriction increase longevity?", J Assoc Physicians India, 54, pp.504~ (2006)
  18. Qiu ZG, "Hyponatremia of cirrhotic ascites", J Clin Hepatobiliary Dis, 10, pp.165~166 (1994)
  19. Gu XB, "36 cases of acute low sodium syndrome complicated by cirrhotic ascites", J Sino-Jpn Friendsh Hosp, 14, pp.192~ (2000)
  20. Wong F, "New challenge of hepatorenal syndrome: prevention and treatment", Hepatology, 34, pp.1242~1251 (2001)
  21. Liu JJ, "Disadvantage of sodium restriction in the treatment of cirrhotic ascites and measures", New Med, 34, pp.123~ (2003)

관련 논문AI추천

Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic HorizonsChen Yu, Duan Meili, Gao Yuan, Gao Yunyi, Hou Bing, Liu Xin거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제6호Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation김도영, 김승업, 박준용, 서주희, 안상훈, 전재윤, 한광협연세대학교의과대학 · Yonsei Medical Journal2013 · 제54권 제1호The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunctionAyman Alsebaey, Eman Abdelsamee, Eman Rewisha, Maha Mohammad Elsabaawy, Manar Abdelaal Obada, Shimaa Rashad Abdelhamid, Tary Abdelhamid Salman대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제4호The Association Between the Serum Sodium Level and the Severity of Complications in Liver Cirrhosis김경아, 김남훈, 김종훈, 문영수, 배원기, 이석현, 이준성대한내과학회 · The Korean Journal of Internal Medicine2009 · 제24권 제2호Albumin for End-Stage Liver Disease이준성대한내과학회 · The Korean Journal of Internal Medicine2012 · 제27권 제1호이뇨제 치료에 반응도가 낮은 간경변 환자군에서의 Furosemide 투여 후 요 나트륨 측정의 의의김영훈, 김진배, 박근태, 심성곤, 이민호, 이오영, 조현석, 최호순, 함준수대한간학회 · Clinical and Molecular Hepatology2003 · 제9권 제2003호

이 간행물의 다른 논문 (18건)